Pharma Market OTC & Nutrition Situation MAT 2013 Q2
Upcoming SlideShare
Loading in...5
×
 

Pharma Market OTC & Nutrition Situation MAT 2013 Q2

on

  • 540 views

 

Statistics

Views

Total Views
540
Views on SlideShare
539
Embed Views
1

Actions

Likes
0
Downloads
36
Comments
0

1 Embed 1

http://www.linkedin.com 1

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Pharma Market OTC & Nutrition Situation MAT 2013 Q2 Pharma Market OTC & Nutrition Situation MAT 2013 Q2 Presentation Transcript

  • Pharma OTC & Nutrition Market Situation MAT 2013Q2
  • Indonesia Pharmaceutical Market – MAT 2013Q2 • Indonesia is a big potential market for pharmaceutical industry, with total market size at OKU YEN 4,755 in MAT 2013Q2 • And the pharmaceutical market in Indonesia has grown rapidly at growth +12% in last year, driven by OTC sector growing +15% in 2013Q2 . • In overall the pharmaceutical market growth is outperforming economic growth (6%). • The market growth is expected to continue at the same rate for 2012-2015. 5,000 +12% 4,500 +14% +11% Sales Value Trade OKU YEN (IDR10,583,333,333/OKU YEN) 4,000 3,500 40% 39% +9% 39% 42% 39% +15% ETHICAL +4% 1,000 60% 61% 1,500 58% 61% +15% 500 61% +11% +13% +11% 0 2010 Exchange rate: Constant IDR10,583,333,333/OKU YEN Source: IMS Plus 2013-Q2 2011 Nutrition OTC +15% 2,000 2009 1 3,816 +11% 3,000 2,500 4,187 3,453 3,119 4,755 2012 2013
  • Top 20 Pharma Companies – Ethical & OTC • Based on medication group, in average Top 5 companies in Rx and OTC are dominated by local companies, then only 3 MNCs are in the Top 10 in Ethical market. • Both in Rx and OTC are perfect competition market. • Numbers of companies in Rx: 203 companies, in OTC: 186 companies. Rank Rx (Ethical) Status IND TOTAL ETHICAL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 KALBE GROUP SANBE DEXA MEDICA GROUP NOVARTIS GROUP SANOFI-AVENTIS GRP FAHRENHEIT PFIZER GROUP KIMIA FARMA GROUP MENSA GROUP INDOFARMA GLAXOSMITHKL GRP BAYER INDONESIA SOHO GROUP OTSUKA GROUP ACTAVIS INTERBAT DARYA-VARIA GROUP B.INGELHEIM GROUP PHAROS GROUP ASTRAZENECA 2 Sales Trade MAT 2013Q2 2,818 LOCAL LOCAL LOCAL MNC MNC LOCAL MNC LOCAL LOCAL LOCAL MNC MNC LOCAL LOCAL MNC LOCAL LOCAL MNC LOCAL MNC 395 249 179 119 111 105 90 72 71 69 66 60 51 51 50 49 48 47 47 42 Market Share MAT 2013Q2 Growth CAGR MAT 2013Q2 MAT 2013Q2 100% 11% 13% 14% 9% 6% 4% 4% 4% 3% 3% 3% 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 1% 17% 16% 16% 10% 8% 17% -1% -4% 11% 16% 16% 5% -3% 16% 23% 9% 7% 20% 5% 12% Exchange rate: Constant IDR10,583,333,333/OKU YEN Source: IMS Plus 2013-Q2 15% 15% 12% 20% 13% 17% 4% 11% 13% 11% 10% 9% 14% 9% 28% 7% 11% 20% 14% 9% Rank OTC Sales Trade IND TOTAL OTC 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 SOHO GROUP KALBE GROUP TEMPO GROUP PHAROS GROUP KONIMEX DEXA MEDICA GROUP DARYA-VARIA GROUP GLAXOSMITHKL GRP LAPI NOVELL PHARM BAYER INDONESIA SANBE INTERBAT J&J MERCK INDONESIA GP MENSA GROUP COMBIPHAR GROUP B.INGELHEIM GROUP MAHAKAM BETA FARMA HISAMITSU PHARMA Growth CAGR MAT 2013Q2 MAT 2013Q2 MAT 2013Q2 MAT 2013Q2 1,892 Status Market Share 100% 15% 11% LOCAL LOCAL LOCAL LOCAL LOCAL LOCAL LOCAL MNC LOCAL LOCAL MNC LOCAL LOCAL MNC MNC LOCAL LOCAL MNC 195 179 159 137 102 62 56 54 53 52 40 40 34 31 30 28 27 24 10% 9% 8% 7% 5% 3% 3% 3% 3% 3% 2% 2% 2% 2% 2% 1% 1% 1% 25% -2% 6% 34% 11% 10% 17% 8% 79% 30% 19% 7% 6% -1% 7% -11% -3% 12% 13% 2% 8% 26% 18% 11% 8% 14% 55% 17% 0% -2% 8% 9% 6% -6% 7% 10% LOCAL MNC 24 23 1% 1% 68% 38% 45% 26%
  • OTC Market Description • At registration, drugs are categorised as one of the following: O (strictly controlled narcotics); G (prescription-only, obat keras); W (non-prescription, obat bebas terbatas, with warning label) and F (non-prescription, obat bebas). – • There is a sub-class of G referred to as G2. G2 products are pharmacy-bound, but can be sold over-the-counter if the pharmacist is sure that the customer needs the drug. These drugs cannot be advertised to the public. An alternative method of classification uses different coloured dots on packs: – ‘Red dot’ products consist of G and G2 products. – ‘Blue dot’ OTCs (equivalent to Class W) can be purchased without a ––prescription, but only through licensed drugstores and pharmacies. They have to display warning messages on packages and can be advertised to consumers. – ‘Green dot’ OTCs (Class F drugs) are products available without prescription ––in any outlet e.g. drugstores, supermarkets, peddlers, cigarette kiosks and bookstores. There is no limit to the quantity of drug purchased and advertising to consumers is permitted. Only Blue dot and Green dot drugs can be advertised 3 | Click > Insert > Header & Footer | DDMMYY
  • IMS Prognosis 2013 on OTC • As the pharmacist is commonly the first port of call, there is heavy reliance on over-thecounter (OTC) medicines or under-thecounter prescription drugs, and 30% of the population uses traditional jamu medicines. • Growth in the OTC market is strong, and will be driven by the buoyant economy and expansion of outlets selling these products. Domestic companies in particular will continue to build up their non-Rx-bound businesses, especially in areas such as herbal medicine • Vitamins, minerals and nutritional supplements are the largest non-Rx bound category in sales terms, followed by cough, cold and other respiratory remedies, and then pain relief. • Herbal medicines, particularly modern herbal brands, which are encroaching into the market for conventional OTC medicines, are expected to become an important growth category. Leading local companies already have herbal lines and more local manufacturers especially those unable to meet new quality standards for prescription medicines, will branch out into herbals. 4 | Click > Insert > Header & Footer | DDMMYY
  • OTC & Nutrition Market Based on our own market category definition, Lifestyle Product (incl Multi Vitamin and Tonic) is the leading category is at 18.8% of share with +3.8% growth. The other Top category are Herbal and Skin Vitamin which driving the market growth. +10.3% 2,000.0 1,600.0 MAT 2013Q2 $ Share (%) +11.6% 1,800.0 Lifestyle 19% +9.4% +4.7% 1,400.0 1,200.0 1,000.0 800.0 1,260.2 1,309.9 1,644.1 1,432.4 1,892.0 Skin Vitamin 5% OTC Nutrition Digestive / GI 4% 600.0 Others 57% 400.0 200.0 OTC + Nutrition Lifestyle Herbal Skin Vitamin Digestive / GI Respi Laxative Memory Others 114.2 129.2 141.2 112.3 2009 0.0 2010 2011 2012 MAT 2013Q2 Sales in OKU YEN 2009 2010 1,374.4 1,439.1 339.4 334.8 109.6 109.4 42.9 51.6 47.6 44.9 34.2 38.6 33.2 32.3 6.0 8.2 761.5 819.4 2011 1,573.7 338.5 123.7 53.2 48.0 45.3 36.6 11.3 917.1 45.2 Share (%) 2012 MAT 2013 Q2 2009 1,756.3 1,937.3 100.0% 350.5 363.9 24.7% 166.2 215.8 8.0% 63.4 101.5 3.1% 59.8 70.4 3.5% 51.9 52.3 2.5% 44.2 51.7 2.4% 15.6 17.5 0.4% 1,004.7 1,064.1 55.4% 5 | Click > Insert > Header & Footer | DDMMYY Respi 0% 2010 100.0% 23.3% 7.6% 3.6% 3.1% 2.7% 2.2% 0.6% 56.9% 2011 100.0% 21.5% 7.9% 3.4% 3.0% 2.9% 2.3% 0.7% 58.3% Growth YoY (%) 2012 MAT 2013 Q2 2010 2011 100.0% 100.0% 4.7% 9.3% 20.0% 18.8% -1.4% 1.1% 9.5% 11.1% -0.2% 13.0% 3.6% 5.2% 20.2% 3.1% 3.4% 3.6% -5.7% 6.9% 3.0% 2.7% 12.9% 17.3% 2.5% 2.7% -2.5% 13.1% 0.9% 0.9% 36.7% 38.4% 57.2% 54.9% 7.6% 11.9% Laxative 3% Memory 1% Herbal 11% CAGR 2012 MAT 2013 Q2 09-'13 11.6% 10.3% 9.0% 3.5% 3.8% 1.8% 34.4% 29.9% 18.5% 19.2% 60.1% 24.0% 24.7% 17.7% 10.3% 14.5% 0.8% 11.2% 20.7% 17.1% 11.7% 38.3% 12.0% 30.9% 9.6% 5.9% 8.7%
  • OTC – Lifestyle Market (1) Lifestyle market is dominated and driven by Vitamin subcategory, but still below overall OTC growth. Zooming in, Multivitamins are the top 3 subcategory for Vitamin. Oppositely, Vitamin-Kid suffered negative growth YoY - last year. SUB-CATEGORY ATC IV A11A4 A11B4 A11D4 A11G2 A11E3 A11G1 A11E2 A11D9 A11X9 A11D3 A11E1 A11X2 A11F0 TOTAL OTC - LIFESTYLE MVIT + MIN OTHERS MVIT W/O MIN OTHERS VIT.B1+VIT.B6 &/OR B12 VITAMIN C COMBINATIONS VITAMIN B COMPLEX OTHERS VITAMIN C PLAIN VITAMIN B COMPLEX + VIT C OTHER VITAMIN B1 COMBS ALL OTHER VITAMINS VITAMIN B1 PLAIN VITAMIN B COMPLEX PLAIN VIT B6(PYRIDOXINE) PLAIN VITAMIN B12 PLAIN A13A2 ALL OTHER TONICS S01M0 EYE TONICS&EYE VITAMINS A11B2 A11C3 A11A2 MVIT W/O MIN PAEDIATRIC VITAMIN A & D COMBS MVIT + MIN PAEDIATRIC 6 | Click > Insert > Header & Footer | DDMMYY Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Vitamin Lifestyle - Tonic Lifestyle - Tonic Lifestyle - Eye Lifestyle - Eye Lifestyle - Kid Lifestyle - Kid Lifestyle - Kid Lifestyle - Kid Sales in OKU YEN Share (%) Growth YoY (%) CAGR MAT 2013 Q2 MAT 2013 Q2 MAT 2013 Q2 '09-'13 363.9 100.0% 3.8% 1.8% 59.3 16.3% 12.3% 6.7% 45.4 12.5% 13.0% 0.4% 35.6 9.8% 4.2% 5.9% 29.7 8.2% 22.5% 6.0% 28.1 7.7% -4.0% 3.2% 20.3 5.6% -1.8% 1.6% 14.1 3.9% 11.1% 6.3% 11.2 3.1% 5.7% 11.2% 9.1 2.5% 6.7% 37.6% 3.0 0.8% 35.7% 6.2% 2.7 0.7% 6.3% -3.3% 0.7 0.2% 42.9% 6.9% 0.5 0.1% 97.1% 16.9% 259.8 71.4% 8.8% 5.1% 58.7 16.1% -10.9% -8.7% 58.7 16.1% -10.9% -8.7% 23.2 6.4% 2.2% 0.4% 23.2 6.4% 2.2% 0.4% 10.1 2.8% -2.4% 2.8% 9.4 2.6% -4.7% 7.4% 2.7 0.7% -10.9% -0.5% 22.2 6.1% -4.5% 4.2%
  • OTC – Lifestyle Market (2) Vitamin products are mostly registered as food supplement product at BPOM (local FDA). This subcategory is heavily advertised, and in average the product advertisement show the benefit is to increase stamina, boost imunity and relieve muscle/nerves stiffness. The pacakging range from capsules, chewable/nonchewable tablet, to RTD . The Vitamin products mostly are dominated by Local manufacturers, even though there are some MNC are competing in this category as well. Sub-Category Lifestyle - Vitamin Lifestyle - Tonic Lifestyle - Eye Lifestyle - Kid Sales in OKU YEN Share (%) Growth YoY (%) CAGR MAT 2013 Q2 MAT 2013 Q2 MAT 2013 Q2 '09-'13 259.8 71.4% 8.8% 5.1% 58.7 16.1% -10.9% -8.7% 23.2 6.4% 2.2% 0.4% 22.2 6.1% -4.5% 4.2% Popular Products MAT 2013 Q2 Vit B1+B6+B16 Neurobion (MCK) OKU YEN 14.3 CAGR +3.0 % Vit C Combination Cerebrovit X-Cel (TCN) OKU YEN 15.9 CAGR +6.9% Multivitamin Kid Curcuma Plus (SHO) OKU YEN 9.6 CAGR -7.1% 7 | Click > Insert > Header & Footer | DDMMYY Vit B Complex Hemaviton (TFC) OKU YEN 8.9 CAGR +3.6% Other Vit B+Comb Cerebrovit X-Cel (KLB) OKU YEN 2.0 CAGR +10.7% Vitamin C Plain Vitacimin (TAK) OKU YEN 7.3 CAGR +5.5%
  • OTC – Herbal Herbal category recorded a very high growth at +29.9% yoy and 5 yrs CAGR at +18.5%, this category has been the raising category over the past years. Many of local companies are expanding to launch Herbal products. The usage of Herbal products range from boosting stamina, relieving sleep disorder, and hormonal BPH product. The existing products have been showing positive growth due to affordable price, wide availability, heavy advertisment and high acceptability by most Indonesian. All Herbal products are manufactured and registered by Local products, as their original product development. SUB-CATEGORY ATC IV TOTAL OTC - HERBAL V03X0 ALL OTH.THERAPEUTIC PRDS Herbal - Others A05B0 HEPAT PROTECT-LIPOTROPICS Herbal - Lipo C10B0 ANTI-ATHEROMA NATRL ORIG Herbal - Anti Atheroma G04C9 BPH PRODUCTS OTHER Herbal - BPH N05B5 HERB HYPNOTICS/SEDATIVES Herbal - Hypno A15A0 APPETITE STIMULANTS Herbal - Appetite N06A2 ANTIDEPRESSANTS, HERBALS Herbal - Antidepressant MAT 2013 Q2 Sales in OKU YEN Share (%) Growth YoY (%) CAGR MAT 2013 Q2 MAT 2013 Q2 MAT 2013 Q2 '09-'13 215.8 100.0% 29.9% 18.5% 186.9 86.6% 30.4% 19.6% 18.2 8.4% 13.2% 10.0% 4.9 2.3% 149.1% 46.9% 3.1 1.5% 20.2% 9.5% 1.9 0.9% 67.9% 6.3% 0.8 0.4% -29.7% -4.9% 0.0 0.0% -14.3% -10.1% Popular Products Herbal - Lipo 8% Herbal - Anti Atheroma 2% All Oth Thera Prod Imboot (SHO) OKU YEN 35.5 CAGR +18.7% Hepa Protect-Lipo Bio Curliv (SHO) OKU YEN 3.4 CAGR +90.5% Herbal - BPH 2% Herbal Others 87% Herbal Hypno 1% Herbal Herbal Antidepressa Appetite nt 0% 0% 8 | Click > Insert > Header & Footer | DDMMYY Herb Hypnotic Lelap (SHO) OKU YEN 1.9 CAGR +6.5% BPH Product Batuin (KM7) OKU YEN 2.2 CAGR +12.5%
  • OTC – Skin Vitamin Market Only 2 subcategories: Dermatological and Vitamin E plain, even though both base ingredients are the same (Vitamin E). The growth has been tremendous at +60.1% yoy and 5 yrs CAGR at +24.0%. Some of the products are registered as food supplement at BPOM – except for topical product. The benefit as promoted, is to keep skin healthy, rejuvenate skin to be younger looks, and increase skin moist through internal system. The packaging range from tablet to topikal cream – some topikal product is promoted to erase skin scars or sun burn (i.e Dermatix). One of the biggest product is Nourish Skin from Pharos. It targets young-adult female as to keep their skin shiny and healthy. It’s heavily advertised and available at the top shelf display in all Pharos’ own retail pharmacy chain – Century. ATC IV D11A0 A11X3 TOTAL OTC - SKIN OTHER DERMATOLOGICALS VITAMIN E PLAIN Sales in OKU YEN Share (%) Growth YoY (%) CAGR SUB-CATEGORY MAT 2013 Q2 MAT 2013 Q2 MAT 2013 Q2 '09-'13 101.5 100.0% 60.1% 24.0% Skin - Others 72.8 71.7% 75.3% 22.9% Skin - Vit E 28.7 28.3% 31.2% 27.2% Popular Products in Skin Category Vitamin E Plain Nature-E (D.V) OKU YEN 11.8 CAGR +14.8% Vitamin E Plain Ever E (KOX) OKU YEN 9.8 CAGR +178.8% 9 | Click > Insert > Header & Footer | DDMMYY Other Dermato Nourish Skin (P-I) OKU YEN 43.6 CAGR +14.2% Other Dermato Dermatix (T5F) OKU YEN 5.7 Growth ’12-13 ,+58.2%
  • OTC – Digestive / GI Market GI digestive market is mostly dominated by Anti-Diarrhea products. The Anti-Diarrhea subcategory is one of the most promising subcategory due to high incidence rate in Indonesia. There are two product base ingredients: natural (probiotic & herbal) & chemical. Probiotic is widely used for toddlers diarrhea case, as it’s safe and convenience to be consumed (in powder or liquid form). However, most of the Probiotic pricing is not cheap – in average. The cheaper base ingredient is Attapulgite, a herbal based, and also widely popular among rural population, mostly sold in 4 tablets sachet and widely available at street stalls. Sales in OKU YEN Share (%) Growth YoY (%) CAGR MAT 2013 Q2 MAT 2013 Q2 MAT 2013 Q2 '09-'13 TOTAL OTC - DIGESTIVE / GI 70.4 100.0% 60.1% 24.0% ANTIDIARR MICRO-ORGANISMS Digestive / GI - Anti Diarrhea 25.3 35.9% 50.1% 26.2% INTEST ADSORBENT ANTIDIA Digestive / GI - Anti Diarrhea 20.9 29.7% 2.2% 6.1% DIGESTIVES INC.ENZYMES Digestive / GI - Enzym 7.5 10.6% 7.4% 2.6% OTHER ANTIDIARRHOEALS Digestive / GI - Anti Diarrhea 5.0 7.1% -15.0% 0.6% OTH STOMACH DISORDER PREP Digestive / GI - Stomach Disord 4.5 6.4% 22.4% 9.4% STOMATOLOGICALS Digestive / GI - Stomato 2.9 4.1% 54.7% 0.8% ALL OTHER ANTIULCERANTS Digestive / GI - Antiulcerant 1.6 2.3% -19.0% -3.5% PLAIN ANTIFLATULENTS Digestive / GI - Antiflatulent 1.5 2.1% 34.7% 10.6% ANTI-INFECTIVE ANTIDIARR Digestive / GI - Anti Diarrhea 0.5 0.7% -5.4% 22.3% ANTIFLATULENTS + OTHERS Digestive / GI - Antiflatulent 0.5 0.7% 428.0% #DIV/0! H2 ANTAGONISTS Digestive / GI - Antiulcerant 0.3 0.4% -26.2% -10.5% SUB-CATEGORY ATC IV A07F0 A07B0 A09A0 A07X0 A02C0 A01A0 A02B9 A02A2 A07A0 A02A7 A02B1 MAT 2013 Q2 Digestive / Digestive / GI - Enzym 11% GI Stomato 4% Digestive / GI Antiflatulen t 3% Digestive / GI Antiulceran t 3% Digestive / GI Stomach Disord 6% Digestive / GI - Anti Diarrhea 73% 10 | Click > Insert > Header & Footer | DDMMYY Popular Products Antidiarr Micro Organi Lacto B (NLL) OKU YEN 9.9 CAGR +11.8% Antidiarr Adsorbent Neo Entrostop (KLB) OKU YEN 7.5 CAGR +6.3% Anti diarrhe Other Diapet (SHO) OKU YEN 4.3 CAGR -3.3% Stomach Disorder Fucoidan (SHO) OKU YEN 3.3 CAGR +6.5%
  • OTC - Respiratory The growth of Respiratory category is lower than others, at +0.8% yoy, even though its 5 yrs CAGR is at +11.2%. The product pack ranges from Tablets, Topikal, and Drops and Syrup. The top biggest subcategories are Allergic, Asthma and Cough & Cold. This category, in average, is promoted through electronic media; TV and radio, and printed media. Many reason of its slowing down sales value due to decreasing spending on advertising from local companies. However this category is not seasonal, compared to European countries, the incidence rate is almost stable over the seasons in Indonesia. SUB-CATEGORY ATC IV R04A0 R05D1 R05F0 R03B2 R02A0 R01B0 R01A7 R01A9 R03X2 TOTAL OTC - RESPIRATORY CHEST RUBS & INHALANTS ANTITUSSIVES PLAIN OTHER COUGH & COLD PREPS XANTHINES,SYSTEMIC PHARYNGEAL PREPARATIONS SYSTEMIC NASAL PREPS NASAL DECONGESTANTS OTH TOPICAL NASAL PREPS ALL OTH A-AS & COPD, SYS MAT 2013 Q2 Respi Nasal 14% Respi Alergic 35% Respi Respi Respi Respi Respi Respi Respi Respi Respi - Asthma - Antitusive - Cough & Cold - Alergic - Alergic - Nasal - Nasal - Nasal - Asthma Sales in OKU YEN Share (%) Growth YoY (%) CAGR MAT 2013 Q2 MAT 2013 Q2 MAT 2013 Q2 '09-'13 52.3 100.0% 0.8% 11.2% 11.4 21.9% 46.1% 15.9% 10.1 19.4% -16.6% 18.0% 10.1 19.2% 42.0% 26.1% 7.7 14.8% -40.4% -1.4% 7.1 13.5% 7.2% 4.6% 3.6 7.0% 4.5% 2.4% 1.3 2.4% 17.0% 7.4% 0.9 1.8% 34.1% 27.6% 0.0 0.0% 4800.5% -14.8% Popular Products Respi Asthma 27% Respi Cough & Cold 24% 11 | Click > Insert > Header & Footer | DDMMYY Chest Rubs & Inhalant Transpulmin (T5F) OKU YEN 4.4 CAGR +12.5% Other Cough & Cold Laserin (MEC) OKU YEN 7.5 CAGR +32.2% Xanthines, systemic Neo Napacin (KOX) OKU YEN 4.0 CAGR -12.5% Systemic Nasal Preps Woods Pepermint (SKA) OKU YEN 3.2 CAGR +9.4%
  • OTC – Laxative Laxative category grew at +17.1% yoy and 5 yrs CAGR at +11.7%.. The packs range from tablets to enemas. There is one heavily advertised product; Laxing by Soho, is a herbal based product, the latet CAGR is only at +0.6%. Sales in OKU YEN Share (%) Growth YoY (%) CAGR MAT 2013 Q2 MAT 2013 Q2 MAT 2013 Q2 '09-'13 TOTAL OTC - LAXATIVE 51.7 100.0% 17.1% STIMULANT LAXATIVES Laxative - General 14.5 28.0% 15.3% SLIMMING PREPARATIONS Laxative - Slimming 13.4 25.9% 1.0% LAXATIVE ENEMAS Laxative - General 13.2 25.5% 28.0% BULK-FORMING LAXATIVES Laxative - General 6.5 12.6% 38.5% OSMOTIC LAXATIVES Laxative - Ethical 2.7 5.2% 15.5% OTHER-NON-THERAPEUTIC Laxative - Weight Loss 1.1 2.1% 43.4% FAECAL SOFTENING LAXATIV Laxative - General 0.4 0.7% 38.4% SUB-CATEGORY ATC IV A06A2 V06A0 A06A4 A06A3 A06A6 V07A0 A06A1 11.7% 5.3% 7.6% 26.4% 14.6% 11.3% 11.9% 70.0% Popular Products MAT 2013 Q2 Stimulant Dulcolax (B.I) OKU YEN 7.6 CAGR +12.1% Laxative Weight Loss Laxative 2% Ethical 5% Laxative Slimming 26% Stimulant Laxing (SHO) OKU YEN 6.6 CAGR +0.6% Laxative General 67% 12 | Click > Insert > Header & Footer | DDMMYY Enema Microlax (P-I) OKU YEN 12.9 CAGR +27.0%
  • OTC – Memory Preserve Memory preserve category is smaller than other category in terms of sales value, but with high growth at +12.0% yoy and 5 yrs CAGR at 30.9%. Most of the products are promoted to increase memory and avoid ageing memory capacity. SUB-CATEGORY ATC IV N06D0 C04A1 N06E0 TOTAL OTC - MEMORY NOOTROPICS Memory - Nootropic CEREB.&PERI.VASOTH.EXC CA Memory - Cerebral NEUROTONIC & MISCELL Memory - Neurotonic Sales in OKU YEN Share (%) Growth YoY (%) CAGR MAT 2013 Q2 MAT 2013 Q2 MAT 2013 Q2 '09-'13 17.51 100.0% 12.0% 30.9% 7.81 44.6% 18.7% 80.0% 7.47 42.7% 13.4% 19.4% 2.22 12.7% -9.7% 9.4% MAT 2013 Q2 Popular Products Memory Neurotonic 13% Memory Nootropic 44% Memory Cerebral 43% 13 | Click > Insert > Header & Footer | DDMMYY Nootropic Neulin (FPP) OKU YEN 6.8 CAGR +72.9% Cerebral Soholin (SHO) OKU YEN 2.6 CAGR +64.2%
  • Age Group Population Indonesian population per 2010 national census grew at 1.1% YoY. The population pyramid has shown a shift to a bigger young to middle age group – which resulted to the increasing productive age group between 24 to 54 y.o. The split between Male:Female is almost equal, except a slightly higher in Female Ageing Well group Toddler 10% Ageing well 11% Kids 10% Mature 18% Parentho od 8% Young Parent 8% Population Grouping Toddler Kids Teens Teens adult Young adult Early jobber Young Parent Parenthood Mature Ageing well Total Age Range 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-54 55+ # of Population 22,678,702 23,253,480 22,671,081 20,880,734 19,891,633 21,310,443 19,830,685 18,505,131 42,127,155 26,492,282 237,641,326 14 | Click > Insert > Header & Footer | DDMMYY Teens 9% Early jobber 9% Teens adult 9% Young adult 8% % based on total age group % based on Gender Male Female ALL Male Female ALL 10% 9% 10% 51% 49% 100% 10% 10% 10% 51% 49% 100% 10% 9% 10% 51% 49% 100% 9% 9% 9% 51% 49% 100% 8% 8% 8% 50% 50% 100% 9% 9% 9% 50% 50% 100% 8% 8% 8% 50% 50% 100% 8% 8% 8% 50% 50% 100% 18% 18% 18% 50% 50% 100% 11% 12% 11% 48% 52% 100% 100% 100% 100% 50% 50% 100% Source: sp2010.bps.go.id
  • Indonesia Socio Economic Class - Nielsen & BCG report Nielsen, the leading global market data provider company, publishes yearly consumer segmentations, called Socio Economic Class (SEC) and the single measure/ criteria is heavily based on routine Monthly Household Expenditure (MHE). It’s widely used by consumer goods company or any marketer which targeting consumer/ patient base. It shows the level of economic buying power, from the lowest E class (those who spends MHE below IDR 700K per month to the highest A class (> IDR 3mio per month). From the past 3 years consecutive data below, it tells us that Indonesian middle economic classes (AtoC1) are increasing at +6% average, correlates to the economic growth at +6% yoy. This is also aligned with the latest Boston Consulting Group’s (BCG) report and World Bank’s report on Indonesian middle class BCG’s Report Nielsen’s SES 9% 17% 25% 12% 3% 8% 14% 22% 27% 28% +5% 23% 23% 25% 18% 8% 2010 16% +9% 14% 8% E IDR < 700.000 D IDR 700.001 1.000.000 C2 IDR 1.000.001 - 1.500.000 C1 IDR 1.500.001 - 2.000.000 B IDR 2.000.001 3.000.000 A IDR > 3.000.000 +6% 2011 2012 15 | Click > Insert > Header & Footer | DDMMYY World Bank’s Report – from the economist.com